Premium
Adjunctive raloxifene improves cognition in schizophrenia
Publication year - 2015
Publication title -
the brown university psychopharmacology update
Language(s) - English
Resource type - Journals
eISSN - 1556-7532
pISSN - 1068-5308
DOI - 10.1002/pu.30092
Subject(s) - raloxifene , selective estrogen receptor modulator , placebo , schizophrenia (object oriented programming) , medicine , crossover study , cognition , pharmacology , estrogen receptor , psychiatry , cancer , breast cancer , alternative medicine , pathology
The selective estrogen receptor modulator raloxifene significantly improved memory and attention/processing speed relative to placebo in a 13‐week crossover trial that included both men and women with schizophrenia. Raloxifene did not result in a reduction in symptom severity, however.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom